BACKGROUND: Primary percutaneous coronary intervention (PCI) is more effective on average than fibrinolytic therapy in the treatment of ST-segment-elevation myocardial infarction. Yet, most US hospitals are not equipped for PCI, and fibrinolytic therapy is still widely used. This study evaluated the comparative effectiveness of ST-segment-elevation myocardial infarction regionalization strategies to increase the use of PCI against standard emergency transport and care. METHODS AND RESULTS: We estimated incremental treatment costs and quality-adjusted life expectancies of 2000 patients with ST-segment-elevation myocardial infarction who received PCI or fibrinolytic therapy in simulations of emergency care in a regional hospital system. To increase access to PCI across the system, we compared a base case strategy with 12 hospital-based strategies of building new PCI laboratories or extending the hours of existing laboratories and 1 emergency medical services-based strategy of transporting all patients with ST-segment-elevation myocardial infarction to existing PCI-capable hospitals. The base case resulted in 609 (95% CI, 569-647) patients getting PCI. Hospital-based strategies increased the number of patients receiving PCI, the costs of care, and quality-adjusted life years saved and were cost-effective under a variety of conditions. An emergency medical services-based strategy of transporting every patient to an existing PCI facility was less costly and more effective than all hospital expansion options. CONCLUSION: Our results suggest that new construction and staffing of PCI laboratories may not be warranted if an emergency medical services strategy is both available and feasible.
BACKGROUND: Primary percutaneous coronary intervention (PCI) is more effective on average than fibrinolytic therapy in the treatment of ST-segment-elevation myocardial infarction. Yet, most US hospitals are not equipped for PCI, and fibrinolytic therapy is still widely used. This study evaluated the comparative effectiveness of ST-segment-elevation myocardial infarction regionalization strategies to increase the use of PCI against standard emergency transport and care. METHODS AND RESULTS: We estimated incremental treatment costs and quality-adjusted life expectancies of 2000 patients with ST-segment-elevation myocardial infarction who received PCI or fibrinolytic therapy in simulations of emergency care in a regional hospital system. To increase access to PCI across the system, we compared a base case strategy with 12 hospital-based strategies of building new PCI laboratories or extending the hours of existing laboratories and 1 emergency medical services-based strategy of transporting all patients with ST-segment-elevation myocardial infarction to existing PCI-capable hospitals. The base case resulted in 609 (95% CI, 569-647) patients getting PCI. Hospital-based strategies increased the number of patients receiving PCI, the costs of care, and quality-adjusted life years saved and were cost-effective under a variety of conditions. An emergency medical services-based strategy of transporting every patient to an existing PCI facility was less costly and more effective than all hospital expansion options. CONCLUSION: Our results suggest that new construction and staffing of PCI laboratories may not be warranted if an emergency medical services strategy is both available and feasible.
Authors: Brahmajee K Nallamothu; Martha E Blaney; Susan M Morris; Lori Parsons; Dave P Miller; John G Canto; Hal V Barron; Harlan M Krumholz Journal: Am J Med Date: 2007-08 Impact factor: 4.965
Authors: Peter Moyer; Joseph P Ornato; William J Brady; Leslie L Davis; Chris A Ghaemmaghami; W Brian Gibler; Greg Mears; Vincent N Mosesso; Richard D Zane Journal: Circulation Date: 2007-05-30 Impact factor: 29.690
Authors: David M Kent; Robin Ruthazer; John L Griffith; Joni R Beshansky; Cindy L Grines; Thomas Aversano; Thomas W Concannon; Robert J Zalenski; Harry P Selker Journal: Am J Cardiol Date: 2007-03-26 Impact factor: 2.778
Authors: W J Rogers; J G Canto; C T Lambrew; A J Tiefenbrunn; B Kinkaid; D A Shoultz; P D Frederick; N Every Journal: J Am Coll Cardiol Date: 2000-12 Impact factor: 24.094
Authors: G T O'Connor; H B Quinton; N D Traven; L D Ramunno; T A Dodds; T A Marciniak; J E Wennberg Journal: JAMA Date: 1999-02-17 Impact factor: 56.272
Authors: Jeph Herrin; Lauren E Miller; Dima F Turkmani; Wato Nsa; Elizabeth E Drye; Susannah M Bernheim; Shari M Ling; Michael T Rapp; Lein F Han; Dale W Bratzler; Elizabeth H Bradley; Brahmajee K Nallamothu; Henry H Ting; Harlan M Krumholz Journal: Arch Intern Med Date: 2011-11-28
Authors: Ralf Birkemeyer; Anke Dauch; Alfred Müller; Manfred Beck; Henrik Schneider; Hueseyin Ince; Werner Jung; Steffen Wahler Journal: Health Econ Rev Date: 2013-04-08
Authors: James R Langabeer; Timothy D Henry; Dean J Kereiakes; Jami Dellifraine; Jamie Emert; Zheng Wang; Leilani Stuart; Richard King; Wendy Segrest; Peter Moyer; James G Jollis Journal: J Am Heart Assoc Date: 2013-10-28 Impact factor: 5.501